Sermorelin is a bioidentical peptide consisting of the first 29 amino acids of growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to produce and release growth hormone naturally, supporting body composition, recovery, and overall vitality.

Sermorelin binds to GHRH receptors on somatotroph cells in the anterior pituitary gland, stimulating the synthesis and pulsatile release of endogenous growth hormone. This preserves the body's natural feedback mechanisms, unlike exogenous HGH administration.
Sermorelin is generally well tolerated. Injection-site reactions such as redness or swelling may occur. Some patients experience flushing or dizziness shortly after administration. Results are typically gradual over weeks to months.
Speak with a licensed clinician to find out if Sermorelin is right for your protocol.
Book a Consultation